日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

肿瘤细胞中饱和和单不饱和溶血磷脂酰胆碱代谢：预防转移的潜在治疗靶点

期刊:Lipids in Health and Disease
影响因子:4.2
doi:10.1186/s12944-015-0070-x
Raynor, Anna; Jantscheff, Peter; Ross, Thomas; Schlesinger, Martin; Wilde, Maurice; Haasis, Sina; Dreckmann, Tim; Bendas, Gerd; Massing, Ulrich
肿瘤
肿瘤免疫
代谢
细胞生物学
肿瘤细胞
发表日期：2015
文献求助 收藏

Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It

组织微阵列可重复打孔：其用途及操作方法

期刊:Microarrays
影响因子:
doi:10.3390/microarrays4020245
Lacombe, Aurélien; Carafa, Vincenza; Schneider, Sandra; Sticker-Jantscheff, Melanie; Tornillo, Luigi; Eppenberger-Castori, Serenella
发表日期：2015
文献求助 收藏

Metastasizing, Luciferase Transduced MAT‑Lu Rat Prostate Cancer Models: Follow up of Bolus and Metronomic Therapy with Doxorubicin as Model Drug

转移性荧光素酶转导的 MAT‑Lu 大鼠前列腺癌模型：以阿霉素为模型药物进行推注和节拍疗法的后续治疗

期刊:Cancers
影响因子:
doi:10.3390/cancers3022679
Peter Jantscheff, Norbert Esser, Andreas Geipel, Peter Woias, Vittorio Ziroli, Frank Goldschmidtboing, Ulrich Massing
肿瘤
前列腺癌
发表日期：2011
文献求助 收藏

Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET

mTOR抑制剂依维莫司的抗血管生成/血管效应无法通过FDG/FLT-PET检测到。

期刊:Translational Oncology
影响因子:4.1
doi:10.1593/tlo.10127
Honer, Michael; Ebenhan, Thomas; Allegrini, Peter R; Ametamey, Simon M; Becquet, Mike; Cannet, Catherine; Lane, Heidi A; O'Reilly, Terence M; Schubiger, Pius A; Sticker-Jantscheff, Melanie; Stumm, Michael; McSheehy, Paul Mj
mTOR
发表日期：2010
文献求助 收藏

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

CEACAM6 作为黏附侵袭性大肠杆菌的受体，促进克罗恩病中回肠黏膜的定植。

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI30504
Barnich, Nicolas; Carvalho, Frédéric A; Glasser, Anne-Lise; Darcha, Claude; Jantscheff, Peter; Allez, Matthieu; Peeters, Harald; Bommelaer, Gilles; Desreumaux, Pierre; Colombel, Jean-Frédéric; Darfeuille-Michaud, Arlette
微生物学
信号转导
克罗恩病
CEACAM6
发表日期：2007
文献求助 收藏

Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation

核糖体蛋白S6基因单倍体不足与原肠胚形成过程中p53依赖性检查点的激活有关

期刊:Molecular and Cellular Biology
影响因子:2.7
doi:10.1128/MCB.00751-06
Panić, Linda; Tamarut, Sanda; Sticker-Jantscheff, Melanie; Barkić, Martina; Solter, Davor; Uzelac, Miljana; Grabusić, Kristina; Volarević, Sinisa
发表日期：2006
文献求助 收藏

Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells

细胞融合：一种生成持续增殖的人类肿瘤抗原呈递细胞的方法

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-002-0295-1
Jantscheff, P; Spagnoli, G; Zajac, P; Rochlitz, C F
细胞生物学
肿瘤
肿瘤免疫
发表日期：2002
文献求助 收藏

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

IL-2 转染异种细胞在皮下转移性肿瘤中进行的 I 期临床试验：临床和免疫学发现

期刊:British Journal of Cancer
影响因子:6.4
doi:10.1054/bjoc.2000.1492
E Tartour, M Mehtali, X Sastre-Garau, I Joyeux, C Mathiot, J M Pleau, P Squiban, C Rochlitz, M Courtney, P Jantscheff, R Herrmann, P Pouillart, W H Fridman, T Dorval
免疫
肿瘤
肿瘤细胞
发表日期：2000
文献求助 收藏

Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells

利用细胞因子转染的异种细胞（Vero-IL-2）进行基因治疗转移性实体瘤患者：转基因携带细胞的清除机制

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s002620050581
Jantscheff, P; Herrmann, R; Spagnoli, G; Reuter, J; Mehtali, M; Courtney, M; Rochlitz, C
细胞生物学
基因治疗
IL-2
免疫/内分泌
发表日期：1999
文献求助 收藏